XML 102 R86.htm IDEA: XBRL DOCUMENT v3.24.4
GOODWILL AND OTHER INTANGIBLE ASSETS Text (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Sep. 20, 2024
Jan. 31, 2024
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2022
Intangible Assets, Including Goodwill)          
Goodwill Additions     $ 526 $ 15  
Finite-Lived Intangible Assets, Period Increase (Decrease)     188 50  
Foreign exchange translation impact to other intangible assets     (5)   $ 2
Goodwill and Intangible Asset Impairment [Abstract]          
Goodwill impairment   $ 0 0 0 0
Impairment of finite-lived intangible assets     0   0
Impairment of indefinite-lived intangible assets     6 0 0
Business Acquisition          
Intangible assets written-off     18 7  
Net gain on Divestiture of Business     0 43 0
Proceeds from Divestiture of Businesses     0 50 $ 0
Indefinite-Lived Intangible Assets, Period Increase (Decrease)     (4)    
Diagnostics and Genomics          
Intangible Assets, Including Goodwill)          
Goodwill Additions     526 15  
Business Acquisition          
Goodwill, Transfers   (168)      
Life Sciences and Applied Markets          
Intangible Assets, Including Goodwill)          
Goodwill Additions     0 0  
Business Acquisition          
Goodwill, Transfers   $ 168      
Agilent CrossLab          
Intangible Assets, Including Goodwill)          
Goodwill Additions     0 0  
Purchased technology          
Intangible Assets, Including Goodwill)          
Finite-Lived Intangible Assets, Period Increase (Decrease)     $ 4    
Resolution Bioscience, Inc.          
Goodwill and Intangible Asset Impairment [Abstract]          
Impairment of finite-lived intangible assets       258  
Business Acquisition          
Net gain on Divestiture of Business       43  
Resolution Bioscience, Inc. | Cost of Product and Services          
Goodwill and Intangible Asset Impairment [Abstract]          
Impairment of finite-lived intangible assets       $ 249  
Business Acquisition          
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]       Cost of revenue  
Resolution Bioscience, Inc. | Selling, General and Administrative          
Goodwill and Intangible Asset Impairment [Abstract]          
Impairment of finite-lived intangible assets       $ 9  
Business Acquisition          
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]       Selling, general and administrative  
Acquisition of businesses          
Business Acquisition          
Purchase price for acquisition       $ 51  
BIOVECTRA          
Intangible Assets, Including Goodwill)          
Goodwill Additions $ 526        
Business Acquisition          
Purchase price for acquisition $ 915